Skip to main content
. 2021 Oct 5;8(6):4465–4483. doi: 10.1002/ehf2.13595

Figure 6.

Figure 6

Flow diagram demonstrating remote monitoring and controlling for in‐home patients with HF risks. HF, heart failure; sST2, soluble suppression of tumourigenicity.